ATKINSON EDWARD MORROW III (EVP, Chief Technical Ops. Off.) sold 7.4% of their position (1.75K shares) of VERTEX PHARMACEUTICALS INC / MA on the open market
Open‑market sale worth $806.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/12/2026ACC: 0000875320-26-000038
Officer· EVP, Chief Technical Ops. Off.
Since Feb 2026
-2.62K
Net shares
Net seller
$1.21M
Total sold
1
Open market trades
0B · 1S
2
Total transactions
2.62K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−872.00
Price / share
$468.41
Trade value
$408.45K
% of position
3.5%
2/10/2026
24.67K→23.80K
Common Stock
Direct
Shares
−1.75K
Price / share
$460.43
Trade value
$806.21K
% of position
7.4%
2/11/2026
23.80K→22.05K
Total
Net shares
−2.62K
Net value
-$1.21M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/10/2026 | F · Tax Withholding | −872.00 | $468.41 | $408.45K | 3.5% | 24.67K | 23.80K |
| Common Stock Direct | 2/11/2026 | S · Sale | −1.75K | $460.43 | $806.21K | 7.4% | 23.80K | 22.05K |
| Total | −2.62K | -$1.21M | ||||||
Derivative Transactions0
No derivative transactions reported